Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/73697
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOgunniyi, A.en
dc.contributor.authorMahdi, L.en
dc.contributor.authorTrappetti, C.en
dc.contributor.authorVerhoeven, N.en
dc.contributor.authorMermans, D.en
dc.contributor.authorVan der Hoek, M.en
dc.contributor.authorPlumptre, C.en
dc.contributor.authorPaton, J.en
dc.date.issued2012en
dc.identifier.citationInfection and Immunity, 2012; 80(9):3268-3278en
dc.identifier.issn0019-9567en
dc.identifier.issn1098-5522en
dc.identifier.urihttp://hdl.handle.net/2440/73697-
dc.description.abstractStreptococcus pneumoniae (the pneumococcus) continues to be responsible for a high level of global morbidity and mortality resulting from pneumonia, bacteremia, meningitis, and otitis media. Here we have used a novel technique involving niche-specific, genome-wide in vivo transcriptomic analyses to identify genes upregulated in distinct niches during pathogenesis after intranasal infection of mice with serotype 4 or 6A pneumococci. The analyses yielded 28 common, significantly upregulated genes in the lungs relative to those in the nasopharynx and 25 significantly upregulated genes in the blood relative to those in the lungs in both strains, some of which were previously unrecognized. The role of five upregulated genes from either the lungs or the blood in pneumococcal pathogenesis and virulence was then evaluated by targeted mutagenesis. One of the mutants (∆malX) was significantly attenuated for virulence in the lungs, two (∆aliA and ∆ilvH) were significantly attenuated for virulence in the blood relative to the wild type, and two others (∆cbiO and ∆piuA) were completely avirulent in a mouse intranasal challenge model. We also show that the products of aliA, malX, and piuA are promising candidates for incorporation into multicomponent protein-based pneumococcal vaccines currently under development. Importantly, we suggest that this new approach is a viable complement to existing strategies for the discovery of genes critical to the distinct stages of invasive pneumococcal disease and potentially has broad application for novel protein antigen discovery in other pathogens such as S. pyogenes, Haemophilus influenzae type b, and Neisseria meningitidis.en
dc.description.statementofresponsibilityAbiodun D. Ogunniyi, Layla K. Mahdi, Claudia Trappetti, Nadine Verhoeven, Daphne Mermans, Mark B. Van der Hoek, Charles D. Plumptre and James C. Patonen
dc.language.isoenen
dc.publisherAmer Soc Microbiologyen
dc.rightsCopyright © 2012 by the American Society for Microbiology.en
dc.subjectNasopharynx; Animals; Mice; Streptococcus pneumoniae; Bacteremia; Pneumococcal Infections; Pneumonia, Bacterial; Virulence Factors; Gene Expression Profilingen
dc.titleIdentification of genes that contribute to the pathogenesis of invasive Pneumococcal Disease by in vivo transcriptomic analysisen
dc.typeJournal articleen
dc.identifier.rmid0020121951en
dc.identifier.doi10.1128/IAI.00295-12en
dc.identifier.pubid23196-
pubs.library.collectionMolecular and Biomedical Science publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidOgunniyi, A. [0000-0001-9308-5629]en
dc.identifier.orcidMahdi, L. [0000-0002-5878-8385]en
dc.identifier.orcidTrappetti, C. [0000-0001-8272-0068]en
dc.identifier.orcidPaton, J. [0000-0001-9807-5278]en
Appears in Collections:Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.